Farnum Rhonda
SVP, COMM & MEDICAL AFFAIRS
Farnum Rhonda has filed 10 SEC Form 4 filings (19 transaction rows) across 1 company, with disclosures dating back to 2025. 10 of those filings fall inside the rolling window. Most recent filing: Sep 25, 2026.
On the most recent filing, Farnum Rhonda is listed as SVP, COMM & MEDICAL AFFAIRS at Theravance Biopharma, Inc. Inside the rolling window, Farnum Rhonda reported no open-market purchases and 4 open-market sales totaling $1.5M in TBPH. The largest disclosed transaction in the window is a sale of 31,067 TBPH shares on Dec 3, 2025, worth $583K.
Companies traded
Other insiders at TBPH
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$1.5M
reported sales (SEC code S)
Companies
1
in the rolling window
Frequently asked questions
How many SEC Form 4 filings has Farnum Rhonda made?
Farnum Rhonda has filed 10 SEC Form 4 filings (19 transaction rows) across 1 company since 2025.
Which companies does Farnum Rhonda trade?
Farnum Rhonda has filed SEC Form 4 disclosures for 1 company, including TBPH.
When was Farnum Rhonda's most recent SEC Form 4 filing?
Farnum Rhonda's most recent SEC Form 4 filing on Tracefour is dated Sep 25, 2026.
What is Farnum Rhonda's job title?
On the most recent SEC Form 4 filings tracked by Tracefour, Farnum Rhonda is listed as SVP, COMM & MEDICAL AFFAIRS.
What is Farnum Rhonda's total buy and sell value in the current window?
Inside the rolling retention window, Farnum Rhonda bought $0 and sold $1.5M based on SEC Form 4 filings.
What was Farnum Rhonda's largest disclosed transaction?
The largest disclosed transaction in the current window is a sale of 31,067 TBPH shares on 2025-12-03, worth $583K, per SEC Form 4 filings.